Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001072613-11-000195
Filing Date
2011-02-14
Accepted
2011-02-14 10:32:00
Documents
1
Group Members
ALAN G. WALTONJONATHAN J. FLEMINGMRNA FUND II LPOBP MANAGEMENT IV LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13GA - OXFORD acadia-sch13ga_17016.htm SC 13G/A 67858
  Complete submission text file 0001072613-11-000195.txt   69780
Mailing Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121 858-558-2871
ACADIA PHARMACEUTICALS INC (Subject) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80011 | Film No.: 11602927
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 222 BERKELEY STREET SUITE 1650 BOSTON MA 02116 6173577474
OXFORD BIOSCIENCE PARTNERS IV LP (Filed by) CIK: 0001140484 (see all company filings)

EIN.: 043556435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A